celecoxib has been researched along with Alveolitis, Fibrosing in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although pulmonary dosing of large porous particles has been shown to sustain drug delivery for a few days, there are no reports on safety or long term delivery." | 5.39 | Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose. ( Dhanda, DS; Kompella, UB; Mirvish, SS; Tyagi, P, 2013) |
| "The case history is described of an elderly man with rheumatoid arthritis receiving treatment with sulfasalazine and the cyclooxygenase-2 inhibitor celecoxib who presented with severe shortness of breath, cough, and decreased exercise tolerance." | 3.71 | Migratory pulmonary infiltrates in a patient with rheumatoid arthritis. ( Aranda, CP; Cassai, N; Mehandru, S; Sidhu, GS; Smith, RL, 2002) |
| "Although pulmonary dosing of large porous particles has been shown to sustain drug delivery for a few days, there are no reports on safety or long term delivery." | 1.39 | Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose. ( Dhanda, DS; Kompella, UB; Mirvish, SS; Tyagi, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhanda, DS | 1 |
| Tyagi, P | 1 |
| Mirvish, SS | 1 |
| Kompella, UB | 1 |
| Gore, E | 1 |
| Mehandru, S | 1 |
| Smith, RL | 1 |
| Sidhu, GS | 1 |
| Cassai, N | 1 |
| Aranda, CP | 1 |
1 review available for celecoxib and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Celecoxib and radiation therapy in non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Celecoxib; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topi | 2004 |
2 other studies available for celecoxib and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzo(a)pyrene; Bron | 2013 |
Migratory pulmonary infiltrates in a patient with rheumatoid arthritis.
Topics: Aged; Airway Obstruction; Antirheumatic Agents; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inh | 2002 |